Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.

BACKGROUND AND PURPOSE The acetazolamide effect is thought to reach a maximum at 10 to 20 minutes after administration. However, we sometimes encountered patients who showed a transient deterioration of ischemic symptoms several minutes after acetazolamide administration. We therefore considered that a steal phenomenon may occur before the acetazolamide effect reaches a maximum. We evaluated the time dependency of the acetazolamide effect on cerebral hemodynamics in patients with severe stenosis or occlusion of the unilateral internal carotid artery. METHODS The subjects consisted of 13 patients with severe stenosis or occlusion of the unilateral internal carotid artery. Regional cerebral blood flow was measured at the resting state and at 5 and 20 minutes after the intravenous administration of 1 g acetazolamide by the use of the [15O]H2O bolus-injection method and positron emission tomography. The steal phenomenon was interpreted as positive when the regional cerebral blood flow values decreased by more than 10% after the administration of acetazolamide in more than one region of interest. RESULTS A steal phenomenon was observed in 5 of 13 patients at 5 minutes after acetazolamide administration on the occlusive side, whereas it was observed in only 1 patient at 20 minutes. Thus, this phenomenon was observed more frequently in the early phase of the acetazolamide test. It was also observed more frequently in patients with poorly developed collateral circulation. CONCLUSIONS Our acetazolamide [15O]H2O positron emission tomography study revealed an early steal phenomenon at 5 minutes after intravenous administration of acetazolamide, which may be a cause of the transient deterioration of ischemic symptoms during the acetazolamide test.

[1]  J. Meyer,et al.  Interaction of cerebral hemodynamics and metabolism , 1961, Neurology.

[2]  E. J. Hoffman,et al.  Quantitative Measurement of Local Cerebral Blood Flow in Humans by Positron Computed Tomography and 15O-Water , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  M D Devous,et al.  The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography. , 1988, Investigative radiology.

[4]  F. Regli,et al.  Effects of Acetazolamide on Cerebral Ischemia and Infarction After Experimental Occlusion of Middle Cerebral Artery , 1971, Stroke.

[5]  S. Cotev,et al.  Carbonic acidosis and cerebral vasodilation after Diamox. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[6]  T. Maren,et al.  Carbonic anhydrase: chemistry, physiology, and inhibition. , 1967, Physiological reviews.

[7]  F. Chollet,et al.  SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. , 1989, Stroke.

[8]  N. Lassen,et al.  Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery. , 1986, Stroke.

[9]  O B Paulson,et al.  Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. , 1984, The Journal of clinical investigation.

[10]  Jens Frahm,et al.  The Effect of Acetazolamide on Regional Cerebral Blood Oxygenation at Rest and under Stimulation as Assessed by MRI , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  F. Plum,et al.  The toxic effects of carbon dioxide and acetazolamide in hepatic encephalopathy. , 1960, The Journal of clinical investigation.

[12]  J. Meyer,et al.  Carbonic anhydrase inhibition and cerebral venous blood gases and ions in man. Demonstration of increased oxygen availability to ischemic brain. , 1966, Archives of internal medicine.

[13]  E. Højer‐Pedersen Effect of acetazolamide on cerebral blood flow in subacute and chronic cerebrovascular disease. , 1987, Stroke.